These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 79045)

  • 1. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
    Ninane G; Joly J; Kraytman M; Piot P
    Lancet; 1978 Jul; 2(8083):257. PubMed ID: 79045
    [No Abstract]   [Full Text] [Related]  

  • 2. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Branhamella infection].
    Nagatake T
    Rinsho Byori; 1985 Aug; 33(8):884-91. PubMed ID: 3908748
    [No Abstract]   [Full Text] [Related]  

  • 4. Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.
    Wallace RJ; Steele LC; Brooks DL; Luman JI; Wilson RW; McLarty JW
    Antimicrob Agents Chemother; 1985 Jun; 27(6):912-5. PubMed ID: 3875310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
    Eliasson I; Kamme C
    Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.
    McLeod DT; Ahmad F; Croughan MJ; Calder MA
    Drugs; 1986; 31 Suppl 3():109-12. PubMed ID: 3732080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
    Calder MA; Croughan MJ; McLeod DT; Ahmad F
    Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
    Cunha BA
    Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of clavulanic acid and amoxycillin (Augmentin) in the treatment of patients infected with penicillinase producing gonococci.
    De Koning GA; Tio D; Coster JF; Coutinho RA; Ansink-Schipper MC
    J Antimicrob Chemother; 1981 Jul; 8(1):81-2. PubMed ID: 6788750
    [No Abstract]   [Full Text] [Related]  

  • 13. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Nov; 22(5):337-62. PubMed ID: 7037354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
    Shurin PA; Van Hare GF
    Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxycillin in the treatment of respiratory tract infection in children.
    Price JD; Harding JW
    Br J Clin Pract; 1975 Aug; 29(8):203-6. PubMed ID: 1100085
    [No Abstract]   [Full Text] [Related]  

  • 18. Branhamella catarrhalis as an indirect pathogen.
    Wardle JK
    Drugs; 1986; 31 Suppl 3():93-6. PubMed ID: 3732085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Respiratory tract infection with Branhamella catarrhalis].
    Matsumoto K; Nagatake T; Uzuka Y; Rikitomi N; Noguchi Y
    Nihon Naika Gakkai Zasshi; 1982 Dec; 71(12):1696-702. PubMed ID: 6984859
    [No Abstract]   [Full Text] [Related]  

  • 20. [Branhamella catarrhalis in infectious pathology of the respiratory tract].
    Le Faou A; Rio A
    Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.